Aprogen Biologics Inc. (KRX:003060)
1,338.00
+3.00 (0.22%)
Nov 2, 2026, 3:30 PM KST
| Market Cap | 21.66B -80.1% |
| Revenue (ttm) | 86.18B +26.1% |
| Net Income | -78.30B |
| EPS | -5,853.18 |
| Shares Out | 16.18M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 47,767 |
| Open | 1,379.00 |
| Previous Close | 1,335.00 |
| Day's Range | 1,324.00 - 1,379.00 |
| 52-Week Range | 1,324.00 - 9,945.00 |
| Beta | -0.21 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |